Phase 1 Study of Sipuleucel-T and Ipilimumab in Combination for Advanced Prostate Cancer
Phase of Trial: Phase I
Latest Information Update: 10 Feb 2018
At a glance
- Drugs Ipilimumab (Primary) ; Sipuleucel-T (Primary)
- Indications Prostate cancer
- Focus Pharmacodynamics
- 10 Feb 2018 Results assessing the outcome and survival of the 6 surviving men, presented at the 2018 Genitourinary Cancers Symposium.
- 23 Aug 2017 Status changed from active, no longer recruiting to completed.
- 10 Jun 2017 Biomarkers information updated